Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma

Fig. 7

A–D Differences in the IPS between the HHSG and LHSG. The A IPS, B IPS-CTLA4, C IPS-PD1/PD-L1/PD- L2, and D IPS-PD1/PD-L1/PD-L2 + CTLA4 were significantly higher for the HHSG than the LHSG. E TIDE scores between the HHSG and LHSG (***P < 0.001). F HS between the cisplatin-sensitive and cisplatin-resistant groups. IPS Immunophenoscores, HHSG high hypoxia score group, LHSG low hypoxia score group, TIDE Tumor Immune Dysfunction and Exclusion

Back to article page